Tvardi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	21.42	31.61	51.78	63.74	13.45	31.68
Short-Term Investments	15.04	-	48.98	81.66	153.58	149.24
Cash & Short-Term Investments	36.46	31.61	100.76	145.4	167.04	180.93
Cash Growth	-13.26%	-68.62%	-30.70%	-12.95%	-7.68%	16.72%
Accounts Receivable	-	-	2.77	3.26	-	-
Other Receivables	-	-	1.25	1.19	1.15	2.06
Total Trade Receivables	-	-	4.02	4.45	1.15	2.06
Inventory	-	-	2.82	2.38	2.58	-
Other Current Assets	1.98	0.07	8.56	16.68	2.52	12.08
Total Current Assets	38.44	31.69	116.16	168.91	173.29	195.07
Net Property, Plant & Equipment	0.22	0.3	8.19	1.98	3.6	5.12
Other Intangible Assets	0.34	0.39	-	-	-	-
Long-Term Investments	-	-	-	11.35	69.75	70.57
Other Long-Term Assets	0.02	2.83	1.5	-	0.41	0.41
Total Assets	39.02	35.2	125.84	182.24	247.06	271.16
Accounts Payable	4.08	2.19	25.59	21.54	15.86	16.88
Accrued Expenses	6.85	8.08	-	-	-	-
Current Portion of Leases	0.11	0.1	-	1.92	1.76	1.6
Total Current Liabilities	11.04	10.37	25.59	23.46	17.62	18.48
Long-Term Leases	0.12	0.2	6.09	-	1.92	3.67
Other Long-Term Liabilities	-	30.26	37.08	-	-	-
Total Long-Term Liabilities	0.12	30.46	43.17	-	1.92	3.67
Total Liabilities	11.16	40.83	68.76	23.46	19.53	22.16
Common Stock	0.01	0	0.01	0.05	0.05	0.05
Additional Paid-in Capital	131.03	1.1	742.09	726.63	708.59	641.2
Accumulated Other Comprehensive Income	0.01	-	-0.26	-1.67	-0.36	0.07
Retained Earnings	-103.18	-92.24	-684.75	-566.23	-480.76	-392.32
Total Common Shareholders' Equity	27.87	-91.13	57.09	158.78	227.52	249
Minority Interest	-	85.5	-	-	-	-
Shareholders' Equity	27.87	-5.63	57.09	158.78	227.52	249
Total Liabilities & Equity	39.02	35.2	125.84	182.24	247.06	271.16
Total Debt	0.23	0.3	6.09	1.92	3.67	5.28
Net Cash (Debt)	36.23	31.31	94.67	143.48	163.36	175.65
Net Cash Growth	15.72%	-66.93%	-34.02%	-12.17%	-7.00%	16.57%
Net Cash Per Share	1.64	1.63	4.95	96.27	115.95	131.97
Book Value	27.87	-91.13	57.09	158.78	227.52	249
Book Value Per Share	1.26	-4.75	2.98	106.54	161.49	187.08
Tangible Book Value	27.53	-91.52	57.09	158.78	227.52	249
Tangible Book Value Per Share	1.25	-4.77	2.98	106.54	161.49	187.08

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q